| scholarly article | Q13442814 |
| P2093 | author name string | Bruce N Cronstein | |
| Aránzazu Mediero | |||
| P2860 | cites work | CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis | Q84566841 |
| Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(₂A) receptor | Q84571966 | ||
| Protein kinase a mediated anti-inflammatory effects exerted by adenosine treatment in mouse chondrocytes stimulated with IL-1β | Q85268787 | ||
| Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1 | Q22306225 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| Molecular action of methotrexate in inflammatory diseases | Q24534771 | ||
| The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart | Q24540404 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Adenosine receptors as therapeutic targets | Q24632095 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor | Q27674275 | ||
| Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 | ||
| Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro | Q28188795 | ||
| Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 | ||
| Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes | Q30160213 | ||
| Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells | Q32065053 | ||
| Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice | Q33783389 | ||
| The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. | Q33909650 | ||
| Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. | Q33919462 | ||
| Pharmacology of cloned P2X receptors | Q33932194 | ||
| Purinergic signalling and bone remodelling. | Q34021414 | ||
| A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo | Q34031056 | ||
| P2 purinergic receptors: modulation of cell function and therapeutic potential | Q34084722 | ||
| Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells | Q34660775 | ||
| Subclasses of external adenosine receptors | Q34661950 | ||
| Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development. | Q34686068 | ||
| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update | Q34701303 | ||
| Regulation of bone resorption and formation by purines and pyrimidines | Q35161577 | ||
| Signalling from adenosine receptors to mitogen-activated protein kinases | Q35166514 | ||
| CD73-generated adenosine promotes osteoblast differentiation | Q35612746 | ||
| Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations | Q35835243 | ||
| Adenosine A(2A) receptor ligation inhibits osteoclast formation. | Q35951939 | ||
| Cellular distribution and functions of P2 receptor subtypes in different systems | Q35952737 | ||
| Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling. | Q35953968 | ||
| Adenosine A2A receptor activation prevents wear particle-induced osteolysis | Q36067491 | ||
| Overview of the P2 receptors | Q36106314 | ||
| Purine and pyrimidine receptors | Q36765468 | ||
| The bone microenvironment in metastasis; what is special about bone? | Q37028803 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| Bone as an endocrine organ. | Q37527342 | ||
| Adenosine receptors as drug targets | Q37691817 | ||
| Osteoblast physiology in normal and pathological conditions | Q37814193 | ||
| Functional selectivity of adenosine receptor ligands | Q37872220 | ||
| Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future | Q37975129 | ||
| Is there a basis for distinguishing two types of P2-purinoceptor? | Q39497248 | ||
| Contrasting effects of A1 and A2b adenosine receptors on adipogenesis | Q39512378 | ||
| Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63. | Q40092493 | ||
| Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields | Q40183574 | ||
| Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The effects of glutamate and protection by purines | Q40292346 | ||
| The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line | Q40323790 | ||
| Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: possible mechanism of MTX osteopathy. | Q40821151 | ||
| ATP and adenosine act as a mitogen for osteoblast-like cells (MC3T3-E1). | Q42816768 | ||
| Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis | Q43559278 | ||
| Effects of an adenosine kinase inhibitor and an adenosine deaminase inhibitor on accumulation of extracellular adenosine by equine articular chondrocytes | Q43590899 | ||
| Chondrocytes respond to adenosine via A(2)receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor | Q43857601 | ||
| Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis | Q44486779 | ||
| Endogenously produced adenosine regulates articular cartilage matrix homeostasis: enzymatic depletion of adenosine stimulates matrix degradation | Q44849347 | ||
| Inhibition of adenosine kinase attenuates interleukin-1- and lipopolysaccharide-induced alterations in articular cartilage metabolism | Q45280275 | ||
| Identification of proteins secreted by human osteoblastic cells in culture | Q46128068 | ||
| Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes | Q46293817 | ||
| Purinergic receptors | Q46382093 | ||
| Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin | Q46898246 | ||
| The stimulation of adenosine 2A receptor reduces inflammatory response in mouse articular chondrocytes treated with hyaluronan oligosaccharides. | Q47384513 | ||
| Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis | Q50115228 | ||
| Purinergic transmitters inhibit bone formation by cultured osteoblasts. | Q52192188 | ||
| Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression. | Q52536557 | ||
| P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration. | Q54620269 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells | Q59673298 | ||
| Neurotransmitter regulation of cytosolic calcium in osteoblast-like bone cells | Q69358248 | ||
| Characterization of adenosine receptors in bone. Studies on the effect of adenosine analogues on cyclic AMP formation and bone resorption in cultured mouse calvaria | Q69810732 | ||
| Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: A mechanism for methotrexate-induced nodulosis in rheumatoid arthritis | Q73491938 | ||
| Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells | Q74536219 | ||
| IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis | Q80221332 | ||
| Role of cell-matrix interactions in osteoclast differentiation | Q81511726 | ||
| Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1β | Q83886779 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 290-300 | |
| P577 | publication date | 2013-03-14 | |
| P1433 | published in | Trends in Endocrinology and Metabolism | Q15265727 |
| P1476 | title | Adenosine and bone metabolism | |
| P478 | volume | 24 |
| Q64113819 | Absence of cytotoxic and inflammatory effects following in vitro exposure of chondrogenically-differentiated human mesenchymal stem cells to adenosine, lidocaine and Mg solution |
| Q49374355 | Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis. |
| Q37256441 | Adenosine A2B receptors play an important role in bone homeostasis. |
| Q64093571 | Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma |
| Q64944461 | Bone Marrow Adipose Tissue and Skeletal Health. |
| Q40932491 | Bone regeneration in critical bone defects using three-dimensionally printed β-tricalcium phosphate/hydroxyapatite scaffolds is enhanced by coating scaffolds with either dipyridamole or BMP-2. |
| Q92032309 | CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis |
| Q91598371 | Dipyridamole Augments Three-Dimensionally Printed Bioactive Ceramic Scaffolds to Regenerate Craniofacial Bone |
| Q35410561 | Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein-2. |
| Q38655694 | Ecto-5'-nucleotidase (CD73) regulates bone formation and remodeling during intramembranous bone repair in aging mice |
| Q38929939 | Effects of tofacitinib on nucleic acid metabolism in human articular chondrocytes |
| Q37475686 | Electrical stimulation enhances cell migration and integrative repair in the meniscus |
| Q33705612 | Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression. |
| Q64954495 | Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation. |
| Q90385450 | Functionally graded multilayer scaffolds for in vivo osteochondral tissue engineering |
| Q98165967 | Identification of Adenosine Deaminase Inhibitors by Metal-binding Pharmacophore Screening |
| Q33569074 | Ketotic hypercalcemia: a case series and description of a novel entity |
| Q35692423 | Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization |
| Q47863015 | Longitudinal bone growth is impaired by direct involvement of caffeine with chondrocyte differentiation in the growth plate |
| Q64235092 | Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase |
| Q64249187 | Neuropeptide W regulates proliferation and differentiation of ATDC5: Possible involvement of GPR7 activation, PKA and PKC-dependent signalling cascades |
| Q38289071 | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. |
| Q38991169 | Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals |
| Q36901374 | Psoralen and Isopsoralen Ameliorate Sex Hormone Deficiency-Induced Osteoporosis in Female and Male Mice. |
| Q37442054 | Regulation of bone and cartilage by adenosine signaling. |
| Q35865353 | Salicylic Acid-Based Polymers for Guided Bone Regeneration Using Bone Morphogenetic Protein-2 |
| Q38659134 | TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production |
| Q94553807 | The Adenosine A2A Receptor Agonist Accelerates Bone Healing and Adjusts Treg/Th17 Cell Balance through Interleukin 6 |
| Q47109047 | The Inactivation of ERK1/2, p38 and NF-kB Is Involved in the Down-Regulation of Osteoclastogenesis and Function by A2B Adenosine Receptor Stimulation |
| Q37736282 | The effect of caffeine on orthodontic tooth movement in rats |
| Q56262600 | The role of 3D printing in treating craniomaxillofacial congenital anomalies |
| Q91662693 | Therapeutic potentials and modulatory mechanisms of fatty acids in bone |
| Q40471318 | Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism. |
| Q89107012 | Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials |
| Q38232436 | Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche. |
| Q89573871 | [A novel calcium phosphate cement pre-loaded with chitosan and small molecule adenosine for repairing large cranial defects in rats] |
Search more.